Studies by Zhou et al. show that targeting PTBP3-mediated COX11 splicing triggers cuproptosis, which inhibits gastric cancer peritoneal metastasis across cell, animal, and clinical models (Zhou et al., 2025). This evidence concerns the gene COX11 and gastric cancer.